Details
Stereochemistry | ACHIRAL |
Molecular Formula | Xe |
Molecular Weight | 131.293 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Xe]
InChI
InChIKey=FHNFHKCVQCLJFQ-UHFFFAOYSA-N
InChI=1S/Xe
Molecular Formula | Xe |
Molecular Weight | 131.293 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Xenon is a noble gas used as an anesthetic agent. Xenon can associate with amino acid side chains of the active site of enzymes such as serine proteinases (including elastases and collagenases); these enzymes can form a specific binding cavity for single xenon atom without inducing major changes in protein structure. It has been demonstrated that xenon binds within the heme cavity of cytochrome P-450 monooxygenases and is capable of inhibiting the catalytic activity of some enzymes in vitro. Current evidence suggests that inhibition of N-methyl-D-aspartate (NMDA) receptor signaling is the mechanism by which xenon induces anesthesia. Although approved for use in anesthesia in Russia in 2000, it was unavailable for use in western countries until October 2005 when approval for its use was granted in Germany.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:00 GMT 2025
by
admin
on
Mon Mar 31 18:17:00 GMT 2025
|
Record UNII |
3H3U766W84
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN01AX15
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
||
|
FDA ORPHAN DRUG |
461914
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1768
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
||
|
FDA ORPHAN DRUG |
455714
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
||
|
NCI_THESAURUS |
C1940
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
||
|
WHO-ATC |
N01AX15
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3H3U766W84
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
4369
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
DB13453
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
23991
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
Xenon
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
SUB32179
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
100000127076
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
D014978
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
11363
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID5064700
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
Xenon
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
C85247
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
49957
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
m11540
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
49956
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
7440-63-3
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY | |||
|
231-172-7
Created by
admin on Mon Mar 31 18:17:00 GMT 2025 , Edited by admin on Mon Mar 31 18:17:00 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |